Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-8-13
pubmed:abstractText
Voltage-gated sodium (Na) channels contribute to the regulation of cellular excitability due to their role in the generation and propagation of action potentials. They are composed of a pore-forming alpha subunit and are modulated by at least two of four distinct beta subunits (beta1-4). Recent studies have implicated a role for the intracellular domain of beta subunits in modulating Na channel gating and trafficking. In beta3, the intracellular domain contains a serine residue at position 161 that is replaced by an alanine in beta1. In this study, we have probed the functional importance of beta3S161 for modulating Na channel gating. Wild-type beta3 and point mutations beta3S161A or beta3S161E were individually co-expressed in HEK 293 cells stably expressing human Na(v)1.2. WTbeta3 expression increased Na current density, shifted steady-state inactivation in a depolarized direction, and accelerated the kinetics of recovery from inactivation of the Na current. Analogous effects were observed with beta3S161E co-expression. In contrast, beta3S161A abolished the shifts in steady-state inactivation and recovery from inactivation of the Na current, but did increase Na current density. Immunocytochemistry and Western blot experiments demonstrate membrane expression of WTbeta3, beta3S161E, and beta3S161A, suggesting that the differences in Na channel gating were not due to disruptions in beta subunit trafficking. These studies suggest that modification of beta3S161 may be important in modulating Na-channel gating.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-10081962, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-10551819, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-10618304, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-10688874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-10798388, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-11259505, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-11486343, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-11891585, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-11997395, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-12486163, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-12620097, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-12850212, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-12930796, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-1375395, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-14744988, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-14761957, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-15311280, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-15455233, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-15525788, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-15664175, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-16080781, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-16183913, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-16847056, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-17592081, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-17623065, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-17629415, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-17928445, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-17988224, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-18599309, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-18782866, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-2026623, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-2547790, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-3508279, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-364941, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-642007, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-708713, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-7852416, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-8521473, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-8786355, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-9461582, http://linkedlifedata.com/resource/pubmed/commentcorrection/19806359-9697698
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1432-2013
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
460
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
743-53
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
The importance of serine 161 in the sodium channel beta3 subunit for modulation of Na(V)1.2 gating.
pubmed:affiliation
Department of Anesthesiology, University of Virginia Health System, Charlottesville, VA, 22908-0710, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural